Filed: 11/14/2025ACC: 0001615982-25-000006
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $1.78B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$1.78B
Total AUM (reported)
134.16M
Total Shares
Allocation by class
COM$1.50B84.4%
COM NEW$199.31M11.2%
SPONSORED ADS$48.96M2.8%
CLASS A ORD SHS$20.05M1.1%
CL A ORD SHS$7.95M0.4%
ORD SHS$1.64M0.1%
Portfolio Concentration
Top 3$687.57M38.7%
4–10$538.83M30.3%
11–25$488.42M27.5%
Rest$61.87M3.5%
Top 3 weight
38.7%
Top 10 weight
69.0%
Voting Authority Distribution
Total shares with voting rights: 134.16M
Sole
Full voting authority
134.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$337.44M
18.99%
Sole
8.49M
Shared
0.00
None
0.00
METSERA INC
SOLEShares3.75M
TypeSH
Market value$196.27M
11.05%
Sole
3.75M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares13.16M
TypeSH
Market value$153.86M
8.66%
Sole
13.16M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares946.79K
TypeSH
Market value$90.66M
5.10%
Sole
946.79K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$83.79M
4.72%
Sole
3.88M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.73M
TypeSH
Market value$81.96M
4.61%
Sole
6.73M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares4.15M
TypeSH
Market value$79.77M
4.49%
Sole
4.15M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares6.60M
TypeSH
Market value$79.16M
4.46%
Sole
6.60M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares3.23M
TypeSH
Market value$66.04M
3.72%
Sole
3.23M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4M
TypeSH
Market value$57.44M
3.23%
Sole
4M
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares15.56M
TypeSH
Market value$49.64M
2.79%
Sole
15.56M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares576.73K
TypeSH
Market value$48.96M
2.76%
Sole
576.73K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares12.68M
TypeSH
Market value$45.27M
2.55%
Sole
12.68M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.69M
TypeSH
Market value$45.01M
2.53%
Sole
2.69M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares17.86M
TypeSH
Market value$38.93M
2.19%
Sole
17.86M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares960.80K
TypeSH
Market value$37.81M
2.13%
Sole
960.80K
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares5.05M
TypeSH
Market value$34.47M
1.94%
Sole
5.05M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares1.23M
TypeSH
Market value$31.91M
1.80%
Sole
1.23M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares3.22M
TypeSH
Market value$27.79M
1.56%
Sole
3.22M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$27.50M
1.55%
Sole
2.17M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares499.97K
TypeSH
Market value$24.36M
1.37%
Sole
499.97K
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares1.17M
TypeSH
Market value$21.99M
1.24%
Sole
1.17M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares4.63M
TypeSH
Market value$20.05M
1.13%
Sole
4.63M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares2.46M
TypeSH
Market value$17.89M
1.01%
Sole
2.46M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares674.60K
TypeSH
Market value$16.83M
0.95%
Sole
674.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $337.44M 18.99% | 8.49M | 0.00 | 0.00 |
METSERA INCSOLE | COM | 3.75M | SH | $196.27M 11.05% | 3.75M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 13.16M | SH | $153.86M 8.66% | 13.16M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 946.79K | SH | $90.66M 5.10% | 946.79K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $83.79M 4.72% | 3.88M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.73M | SH | $81.96M 4.61% | 6.73M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 4.15M | SH | $79.77M 4.49% | 4.15M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 6.60M | SH | $79.16M 4.46% | 6.60M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 3.23M | SH | $66.04M 3.72% | 3.23M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4M | SH | $57.44M 3.23% | 4M | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 15.56M | SH | $49.64M 2.79% | 15.56M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 576.73K | SH | $48.96M 2.76% | 576.73K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 12.68M | SH | $45.27M 2.55% | 12.68M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.69M | SH | $45.01M 2.53% | 2.69M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 17.86M | SH | $38.93M 2.19% | 17.86M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 960.80K | SH | $37.81M 2.13% | 960.80K | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 5.05M | SH | $34.47M 1.94% | 5.05M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 1.23M | SH | $31.91M 1.80% | 1.23M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 3.22M | SH | $27.79M 1.56% | 3.22M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $27.50M 1.55% | 2.17M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 499.97K | SH | $24.36M 1.37% | 499.97K | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 1.17M | SH | $21.99M 1.24% | 1.17M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 4.63M | SH | $20.05M 1.13% | 4.63M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 2.46M | SH | $17.89M 1.01% | 2.46M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 674.60K | SH | $16.83M 0.95% | 674.60K | 0.00 | 0.00 |
Page 1 of 2